---
title: Paracetamol + Serratiopeptidase + Tramadol
description: >-
  This combination medication is primarily prescribed for the symptomatic
  treatment of moderate to severe pain, particularly when pain is not adequately
  managed by non-opioid analgesics alone.  Conditions it's commonly used for
  include post-operative pain, dental pain, musculoskeletal pain (such as...
is_banned: false
lastModified: '2025-09-22T17:22:09.654Z'
faqs:
  - q: >-
      What is the recommended dosage for Paracetamol + Serratiopeptidase +
      Tramadol?**


      **A:** The initial recommended adult dose is two tablets of 325mg
      paracetamol, 15mg serratiopeptidase and 37.5mg tramadol, or one tablet of
      a doubled strength (if available) every 4-6 hours as needed for pain
      relief, not to exceed eight tablets per day. This should be adjusted based
      on individual patient needs and clinical response.
    a: >-
      A:** The initial recommended adult dose is two tablets of 325mg
      paracetamol, 15mg serratiopeptidase and 37.5mg tramadol, or one tablet of
      a doubled strength (if available) every 4-6 hours as needed for pain
      relief, not to exceed eight tablets per day. This should be adjusted based
      on individual patient needs and clinical response.
  - q: >-
      Can this combination be used in children?**


      **A:** The safety and efficacy in children under 12 have not been
      established and its use is generally not recommended.
    a: >-
      A:** The safety and efficacy in children under 12 have not been
      established and its use is generally not recommended.
  - q: >-
      Is Paracetamol + Serratiopeptidase + Tramadol addictive?**


      **A:** Tramadol, an opioid component, carries the risk of dependence and
      addiction with prolonged use. Prescribe cautiously and monitor for signs
      of misuse.
    a: >-
      A:** Tramadol, an opioid component, carries the risk of dependence and
      addiction with prolonged use. Prescribe cautiously and monitor for signs
      of misuse.
  - q: >-
      What are the serious side effects to watch out for?**


      **A:** Serious side effects include respiratory depression, seizures,
      serotonin syndrome, allergic reactions, and hepatotoxicity.
    a: >-
      A:** Serious side effects include respiratory depression, seizures,
      serotonin syndrome, allergic reactions, and hepatotoxicity.
  - q: >-
      Can this combination be used during pregnancy or breastfeeding?**


      **A:**  It's generally contraindicated in pregnancy, especially in the
      third trimester, and during breastfeeding due to potential risks to the
      fetus/infant.
    a: >-
      A:**  It's generally contraindicated in pregnancy, especially in the third
      trimester, and during breastfeeding due to potential risks to the
      fetus/infant.
  - q: >-
      What are the key drug interactions to be aware of?**


      **A:**  Important drug interactions include those with MAOIs, SSRIs, other
      opioids, benzodiazepines, alcohol, and carbamazepine. These interactions
      can increase the risk of adverse events such as serotonin syndrome,
      respiratory depression, and liver damage.
    a: >-
      A:**  Important drug interactions include those with MAOIs, SSRIs, other
      opioids, benzodiazepines, alcohol, and carbamazepine. These interactions
      can increase the risk of adverse events such as serotonin syndrome,
      respiratory depression, and liver damage.
  - q: >-
      What should patients be advised regarding activities requiring
      alertness?**


      **A:**  Patients should be advised not to drive or operate heavy machinery
      while taking this medication due to potential drowsiness and dizziness.
    a: >-
      A:**  Patients should be advised not to drive or operate heavy machinery
      while taking this medication due to potential drowsiness and dizziness.
  - q: >-
      How does renal or hepatic impairment affect dosage?**


      **A:** Dosage adjustments may be required in patients with renal or
      hepatic dysfunction, depending on the severity of the impairment. Consult
      specialized resources or a nephrologist/hepatologist if needed.
    a: >-
      A:** Dosage adjustments may be required in patients with renal or hepatic
      dysfunction, depending on the severity of the impairment. Consult
      specialized resources or a nephrologist/hepatologist if needed.
  - q: >-
      What is the role of serratiopeptidase in this combination?**


      **A:** Serratiopeptidase, a proteolytic enzyme, is included to reduce
      inflammation and potentially enhance pain relief.
    a: >-
      A:** Serratiopeptidase, a proteolytic enzyme, is included to reduce
      inflammation and potentially enhance pain relief.
  - q: >-
      Can this medication be used for long-term pain management?**


      **A:**  While the combination can manage pain effectively, long-term use
      should be avoided due to the risk of tramadol dependence and potential
      adverse effects from the other components.  Regularly reassess the need
      for continued treatment and consider alternative options for chronic pain
      management.
    a: >-
      A:**  While the combination can manage pain effectively, long-term use
      should be avoided due to the risk of tramadol dependence and potential
      adverse effects from the other components.  Regularly reassess the need
      for continued treatment and consider alternative options for chronic pain
      management.
---
## **Usage**

This combination medication is primarily prescribed for the symptomatic treatment of moderate to severe pain, particularly when pain is not adequately managed by non-opioid analgesics alone.  Conditions it's commonly used for include post-operative pain, dental pain, musculoskeletal pain (such as back pain, joint pain, and muscle ache), menstrual cramps, and toothache. It may also provide relief for fever associated with muscle pain.

**Pharmacological Classification:** Analgesic (combining non-opioid, proteolytic enzyme, and opioid mechanisms)

**Mechanism of Action:** This drug combines three active ingredients with different mechanisms:

* **Paracetamol (Acetaminophen):**  Acts centrally to reduce fever and peripherally to relieve pain, potentially by inhibiting prostaglandin synthesis in the central nervous system and activating descending serotonergic pathways. It has minimal anti-inflammatory activity.

* **Serratiopeptidase:**  A proteolytic enzyme believed to break down proteins that contribute to pain and inflammation, potentially reducing swelling by thinning mucus and other bodily fluids.

* **Tramadol:** A centrally acting opioid analgesic.  It inhibits the reuptake of serotonin and norepinephrine, modulating pain perception in the central nervous system.

## **Alternate Names**

* Paracetamol/Acetaminophen + Serratiopeptidase + Tramadol
* Acetaminophen + Serratiopeptidase + Tramadol Hydrochloride
* Tramadol/Paracetamol + Serratiopeptidase



## **How It Works**

**Pharmacodynamics:**

* **Paracetamol:**  Reduces fever by acting on the hypothalamic heat-regulating center and provides analgesia through central and peripheral mechanisms.
* **Serratiopeptidase:** Decreases inflammation and pain by breaking down bradykinin, fibrin, and other proteins involved in the inflammatory response.
* **Tramadol:** Binds to mu-opioid receptors in the central nervous system, inhibiting pain transmission. It also inhibits serotonin and norepinephrine reuptake, further enhancing pain relief.

**Pharmacokinetics:**

* **Absorption:** All three components are well-absorbed orally. Food may slightly delay the absorption of tramadol.
* **Metabolism:** Paracetamol is primarily metabolized in the liver.  Tramadol is metabolized in the liver via CYP2D6 and CYP3A4 enzymes, forming active metabolites. Serratiopeptidase is presumably broken down in the gastrointestinal tract and absorbed as smaller peptides or amino acids.
* **Elimination:** Paracetamol and its metabolites are primarily excreted in the urine. Tramadol and its metabolites are also mainly excreted renally.


## **Dosage**


### **Standard Dosage**

#### **Adults:**

Initial dose is two tablets of Paracetamol 325mg/Tramadol 37.5mg/Serratiopeptidase 15mg, or one tablet of Paracetamol 650mg/Tramadol 75mg/Serratiopeptidase 30mg (if available), taken orally every 4-6 hours as needed for pain relief.  The maximum daily dose is eight tablets (Paracetamol 2600mg/Tramadol 300mg/Serratiopeptidase 120mg) and should not be exceeded.


#### **Children:**

The safety and efficacy of this combination have not been established in children under 12 years of age.

#### **Special Cases:**

* **Elderly Patients:** Start with lower doses and monitor closely due to age-related physiological changes.
* **Patients with Renal Impairment:** Dosage adjustments may be necessary depending on the degree of impairment.
* **Patients with Hepatic Dysfunction:**  Use with caution and potentially reduce the dosage due to the risk of paracetamol-induced hepatotoxicity. Tramadol dosage reduction might also be necessary. 
* **Patients with Comorbid Conditions:** Exercise caution in patients with respiratory depression, seizures, head injury, or increased intracranial pressure.  


### **Clinical Use Cases**

Dosage in these settings should be individualized based on patient needs and under close monitoring, adhering to maximum daily limits:

* **Intubation:**  Not typically used.
* **Surgical Procedures:** May be used for post-operative pain management.
* **Mechanical Ventilation:** Use cautiously due to the risk of respiratory depression, particularly with tramadol.
* **Intensive Care Unit (ICU) Use:** Dosage should be adjusted based on individual needs and monitored carefully.
* **Emergency Situations:** Not the first-line treatment for acute emergency situations due to potential side effects and slower onset of action.


### **Dosage Adjustments**

Dose adjustments should be based on patient-specific factors including:

* Renal/hepatic function
* Age
* Comorbid conditions



## **Side Effects**

### **Common Side Effects:**

Nausea, vomiting, constipation, dizziness, drowsiness, headache, dry mouth, sweating, itching, anxiety, rash, flushing, stomach upset, weakness, blurred vision


### **Rare but Serious Side Effects:**

Allergic reactions (rash, itching, swelling), respiratory depression, seizures, serotonin syndrome (mental status changes, autonomic instability, neuromuscular abnormalities), hepatotoxicity, addiction.

### **Long-Term Effects:**

Potential for tolerance, dependence, and addiction with prolonged use of tramadol.


### **Adverse Drug Reactions (ADR):**

Serotonin syndrome, anaphylaxis, hepatotoxicity, respiratory depression, seizures


## **Contraindications**

* Hypersensitivity to any of the components
* Severe respiratory depression
* Acute or severe bronchial asthma
* Acute intoxication with alcohol, hypnotics, centrally acting analgesics, opioids, or psychotropic drugs
* Concomitant use of MAO inhibitors
* Severe hepatic impairment
* Pregnancy (especially the third trimester)
* Breastfeeding



## **Drug Interactions**

* **MAOIs:**  Risk of serotonin syndrome.
* **SSRIs, Triptans:** Increased risk of serotonin syndrome.
* **Opioids:**  Additive respiratory depression and other opioid-related side effects.
* **Benzodiazepines:**  Increased risk of drowsiness, respiratory depression, and coma.
* **Alcohol:**  Increased risk of liver damage and CNS depression.
* **Warfarin:** Increased risk of bleeding (with chronic paracetamol use).
* **Carbamazepine:** May decrease the effectiveness of tramadol.
* **Other NSAIDs:** Increased risk of gastrointestinal side effects (not applicable to this combination specifically).


## **Pregnancy and Breastfeeding**

This combination should be avoided during pregnancy and breastfeeding unless the benefits significantly outweigh the risks. Tramadol can cross the placenta and may cause neonatal withdrawal symptoms.  Both paracetamol and tramadol are excreted in breast milk.


## **Drug Profile Summary**

* **Mechanism of Action:** Multimodal analgesic combining non-opioid, proteolytic, and opioid mechanisms.
* **Side Effects:** Nausea, vomiting, constipation, dizziness, drowsiness, headache, addiction potential.
* **Contraindications:** Hypersensitivity, severe respiratory depression, acute asthma, acute intoxication with CNS depressants, concurrent MAOI use, severe hepatic impairment, pregnancy, breastfeeding.
* **Drug Interactions:** MAOIs, SSRIs, opioids, benzodiazepines, alcohol, carbamazepine.
* **Pregnancy & Breastfeeding:** Avoid.
* **Dosage:**  Initial dose is two tablets of Paracetamol 325mg/Tramadol 37.5mg/Serratiopeptidase 15mg every 4-6 hours as needed for pain relief, not exceeding 8 tablets/day.
* **Monitoring Parameters:** Respiratory rate, liver function tests, signs of opioid dependence/withdrawal.


## **Popular Combinations** (This refers to combination therapies that might be used *alongside* this medication, not alternative formulations)

It is important to note that combining this medication with other CNS depressants or serotonergic drugs can increase the risk of adverse effects. Close monitoring is essential.  Combination therapy should only be considered if deemed necessary by a physician and if the benefits clearly outweigh potential risks.


## **Precautions**

* Assess for allergies and history of substance abuse before prescribing.
* Monitor liver and kidney function, especially with prolonged use.
* Caution in patients with respiratory problems, seizure disorders, head injury, or increased intracranial pressure.
* Avoid alcohol while taking this medication.
* Advise patients against driving or operating heavy machinery while taking this medication due to potential drowsiness and dizziness.


## **FAQs (Frequently Asked Questions)**


### **Q1: What is the recommended dosage for Paracetamol + Serratiopeptidase + Tramadol?**

**A:** The initial recommended adult dose is two tablets of 325mg paracetamol, 15mg serratiopeptidase and 37.5mg tramadol, or one tablet of a doubled strength (if available) every 4-6 hours as needed for pain relief, not to exceed eight tablets per day. This should be adjusted based on individual patient needs and clinical response.

### **Q2: Can this combination be used in children?**

**A:** The safety and efficacy in children under 12 have not been established and its use is generally not recommended.


### **Q3: Is Paracetamol + Serratiopeptidase + Tramadol addictive?**

**A:** Tramadol, an opioid component, carries the risk of dependence and addiction with prolonged use. Prescribe cautiously and monitor for signs of misuse.

### **Q4: What are the serious side effects to watch out for?**

**A:** Serious side effects include respiratory depression, seizures, serotonin syndrome, allergic reactions, and hepatotoxicity.

### **Q5: Can this combination be used during pregnancy or breastfeeding?**

**A:**  It's generally contraindicated in pregnancy, especially in the third trimester, and during breastfeeding due to potential risks to the fetus/infant.

### **Q6: What are the key drug interactions to be aware of?**

**A:**  Important drug interactions include those with MAOIs, SSRIs, other opioids, benzodiazepines, alcohol, and carbamazepine. These interactions can increase the risk of adverse events such as serotonin syndrome, respiratory depression, and liver damage.

### **Q7: What should patients be advised regarding activities requiring alertness?**

**A:**  Patients should be advised not to drive or operate heavy machinery while taking this medication due to potential drowsiness and dizziness.

### **Q8:  How does renal or hepatic impairment affect dosage?**

**A:** Dosage adjustments may be required in patients with renal or hepatic dysfunction, depending on the severity of the impairment. Consult specialized resources or a nephrologist/hepatologist if needed.

### **Q9: What is the role of serratiopeptidase in this combination?**

**A:** Serratiopeptidase, a proteolytic enzyme, is included to reduce inflammation and potentially enhance pain relief.


### **Q10: Can this medication be used for long-term pain management?**

**A:**  While the combination can manage pain effectively, long-term use should be avoided due to the risk of tramadol dependence and potential adverse effects from the other components.  Regularly reassess the need for continued treatment and consider alternative options for chronic pain management.

